Potential clinical implications of BRAF mutations in histiocytic proliferations.

Oncotarget · 2014 · PMC4147306 · PMID 24938183

Europe PMC DOI

hedged sentence

1.0000

closest p · 20.0× alpha

1.0000

boldest claim

The sentences

did not reach statistical significanceP =1.00not close (p > 0.1)

localized cases (1 of 4 = 25%); however, these differences did not reach statistical significance ( P =1.00; Fisher's).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.